Aspen Partners with Mytos to Automate Stem Cell Production for Parkinson’s Therapy
Newsroom
Mytos Announces Strategic Partnerships with StemSight, Rinri, and Novadip to Power Next-Generation Cell Therapy Trials
September 3rd, 2025
Collaborations highlight the versatility of Mytos’ iDEM platform across diverse cell types and clinical applications from blindness and hearing loss to complex bone regeneration
Pushing The Frontiers of Human Cell Manufacturing — Mytos Announces $19M Series A
This Startup Just Raised $19 Million To Bring An Industrial Revolution To Biology
Cell manufacturing company raises $19M Series A to increase capacity, staff numbers
Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth